We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOV icon
1026
NOV
NOV
$7.35B
$7.97M 0.02%
406,504
-3,523,333
-90% -$61.7M
HD icon
1027
Home Depot
HD
$335B
$7.96M 0.02%
26,601
-290,815
-92% -$101M
LFTR
1028
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
$7.92M 0.02%
804,291
PRLH
1029
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$7.9M 0.02%
+800,224
New +$7.9M
ALTU
1030
DELISTED
Altitude Acquisition Corp
ALTU
$7.88M 0.01%
792,335
THRY icon
1031
Thryv Holdings
THRY
$184M
$7.87M 0.01%
279,863
-101,132
-27% -$3.17M
PVLA
1032
Palvella Therapeutics
PVLA
$2.03B
$7.87M 0.01%
32,468
+4,921
+18% +$1.29M
FACA
1033
DELISTED
Figure Acquisition Corp. I
FACA
$7.87M 0.01%
804,469
ZLS
1034
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$7.86M 0.01%
812,447
CPRI icon
1035
Capri Holdings
CPRI
$1.82B
$7.84M 0.01%
152,613
-11,573
-7% -$693K
TLSI icon
1036
TriSalus Life Sciences
TLSI
$265M
$7.79M 0.01%
795,519
FISV
1037
Fiserv Inc
FISV
$27.9B
$7.79M 0.01%
76,838
-116,801
-60% -$11.8M
OCA
1038
DELISTED
Omnichannel Acquisition Corp.
OCA
$7.79M 0.01%
780,845
DKS icon
1039
Dick's Sporting Goods
DKS
$18.4B
$7.78M 0.01%
77,779
+32,935
+73% +$3.62M
FIVE icon
1040
Five Below
FIVE
$11.5B
$7.75M 0.01%
48,973
-74,949
-60% -$12.5M
DJTWW
1041
CALL
Trump Media & Technology Group Warrants
DJTWW
$774M
$7.74M 0.01%
120,000
-130,000
-52% -$2.9M
FRSG
1042
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$7.74M 0.01%
793,512
NTLA icon
1043
Intellia Therapeutics
NTLA
$1.49B
$7.73M 0.01%
+106,316
New +$9.01M
NFYS.WS
1044
CALL
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
$7.72M 0.01%
800,912
RS icon
1045
Reliance Steel & Aluminium
RS
$20.6B
$7.7M 0.01%
+42,016
New +$7.27M
THAC
1046
DELISTED
Thrive Acquisition Corporation Class A ordinary shares
THAC
$7.7M 0.01%
770,948
KAHC.WS
1047
CALL
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$7.69M 0.01%
782,569
+32,698
+4% +$24.2K
ATKR icon
1048
Atkore
ATKR
$2.54B
$7.69M 0.01%
78,140
-6,834
-8% -$709K
METC icon
1049
Ramaco Resources Class A
METC
$664M
$7.68M 0.01%
502,229
+375,013
+295% +$5.46M
ZM icon
1050
CALL
Zoom
ZM
$26.7B
$7.67M 0.01%
65,400
-42,600
-39% -$5.79M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.